• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性多发性硬化症:超越身体残疾的视角

Benign multiple sclerosis: looking beyond physical disability.

作者信息

de Almeida David Josué, de Paula Thomas Vieira, Damasceno Alfredo

机构信息

Faculty of Medical Sciences, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.

Department of Neurology, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.

出版信息

Neurol Sci. 2025 Sep 16. doi: 10.1007/s10072-025-08495-y.

DOI:10.1007/s10072-025-08495-y
PMID:40954438
Abstract

BACKGROUND

Previous studies on Benign Multiple Sclerosis (BMS) relied mostly on the Expanded Disability Status Scale (EDSS) for classification. In addition, the underlying mechanisms of BMS are not yet fully understood. Therefore, we analyzed the frequency of BMS when parameters beyond EDSS are included, and BMS neuroimaging correlates.

METHODS

BMS (EDSS ≤ 3.0 after 10 years of onset) and traditional MS (EDSS > 3.0 after the same period) individuals underwent assessment of physical disability, fatigue, depression, and cognition. BMS were further classified according to a stringent EDSS-based criteria (EDSS ≤ 2.0 after 15 years of onset) and as fully benign (no fatigue, depression or cognitive deficit). We quantified lesions in four locations for dissemination in space (DIS). Logistic regression was employed to analyze clinical/demographic and neuroimaging predictors of BMS.

RESULTS

Individuals with traditional MS (n = 23) and BMS (n = 30) had similar frequency of depression. Thirteen (43.3%) BMS individuals had no fatigue, depression or cognitive deficit. Lesions at each DIS location were similarly distributed across groups, except for the spinal cord which was lower in BMS (p = 0.024). After logistic regression, education (OR = 0.839, 95%CI 0.716-0.984) and spinal cord lesions (OR = 1.364, 95%CI 1.054-1.765) were associated with BMS.

CONCLUSIONS

Individuals with the EDSS-based classification of BMS show a similar frequency of depression compared to traditional RRMS, underscoring the need of a broader definition of BMS. Higher education and less spinal cord lesions are associated with the BMS status.

摘要

背景

以往关于良性多发性硬化症(BMS)的研究大多依赖扩展残疾状态量表(EDSS)进行分类。此外,BMS的潜在机制尚未完全明确。因此,我们分析了纳入EDSS以外参数时BMS的发生率以及BMS的神经影像学相关因素。

方法

BMS患者(发病10年后EDSS≤3.0)和传统多发性硬化症(MS)患者(同期EDSS>3.0)接受了身体残疾、疲劳、抑郁和认知方面的评估。BMS患者进一步根据基于EDSS的严格标准进行分类(发病15年后EDSS≤2.0)以及被归类为完全良性(无疲劳、抑郁或认知缺陷)。我们对四个空间扩散(DIS)部位的病灶进行了量化。采用逻辑回归分析BMS的临床/人口统计学和神经影像学预测因素。

结果

传统MS患者(n = 23)和BMS患者(n = 30)的抑郁发生率相似。13名(43.3%)BMS患者无疲劳、抑郁或认知缺陷。除脊髓外,各DIS部位的病灶在各组中的分布相似,BMS患者脊髓病灶较少(p = 0.024)。逻辑回归分析后,受教育程度(OR = 0.839,95%CI 0.716 - 0.984)和脊髓病灶(OR = 1.364,95%CI 1.054 - 1.765)与BMS相关。

结论

基于EDSS分类的BMS患者与传统复发缓解型MS患者的抑郁发生率相似,这突出了对BMS进行更广泛定义的必要性。受教育程度较高和脊髓病灶较少与BMS状态相关。

相似文献

1
Benign multiple sclerosis: looking beyond physical disability.良性多发性硬化症:超越身体残疾的视角
Neurol Sci. 2025 Sep 16. doi: 10.1007/s10072-025-08495-y.
2
Vitamin D for the management of multiple sclerosis.维生素D用于多发性硬化症的管理。
Cochrane Database Syst Rev. 2018 Sep 24;9(9):CD008422. doi: 10.1002/14651858.CD008422.pub3.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Natalizumab for multiple sclerosis.那他珠单抗用于治疗多发性硬化症。
Cochrane Database Syst Rev. 2025 Aug 6;8(8):CD015123. doi: 10.1002/14651858.CD015123.pub2.
5
Efficacy of fingolimod in multiple sclerosis patients with spinal cord involvement: an open-label study.芬戈莫德治疗脊髓受累多发性硬化患者的疗效:一项开放标签研究。
Mult Scler Relat Disord. 2025 Sep;101:106590. doi: 10.1016/j.msard.2025.106590. Epub 2025 Jun 17.
6
Rituximab for relapsing-remitting multiple sclerosis.利妥昔单抗用于复发缓解型多发性硬化症。
Cochrane Database Syst Rev. 2013 Dec 6;2013(12):CD009130. doi: 10.1002/14651858.CD009130.pub3.
7
Teriflunomide for multiple sclerosis.特立氟胺用于治疗多发性硬化症。
Cochrane Database Syst Rev. 2016 Mar 22;3(3):CD009882. doi: 10.1002/14651858.CD009882.pub3.
8
Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.对首次出现提示多发性硬化症临床发作的患者使用疾病修饰药物进行治疗。
Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD012200. doi: 10.1002/14651858.CD012200.pub2.
9
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
10
Siponimod for multiple sclerosis.西尼莫德用于多发性硬化症。
Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD013647. doi: 10.1002/14651858.CD013647.pub2.

本文引用的文献

1
Prognostic value of spinal cord lesion measures in early relapsing-remitting multiple sclerosis.早期复发缓解型多发性硬化症中脊髓病变指标的预后价值。
J Neurol Neurosurg Psychiatry. 2023 Dec 14;95(1):37-43. doi: 10.1136/jnnp-2023-331799.
2
Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?多发性硬化症中的认知障碍、疲劳和抑郁:良性和非良性 MS 之间有区别吗?
Mult Scler Relat Disord. 2023 May;73:104630. doi: 10.1016/j.msard.2023.104630. Epub 2023 Mar 21.
3
Cognitive impairment in benign multiple sclerosis: a multiparametric structural and functional MRI study.
良性多发性硬化症中的认知障碍:一项多参数结构和功能磁共振成像研究
J Neurol. 2020 Dec;267(12):3508-3517. doi: 10.1007/s00415-020-10025-z. Epub 2020 Jul 2.
4
How common is truly benign MS in a UK population?在英国人群中,真正良性的多发性硬化症有多常见?
J Neurol Neurosurg Psychiatry. 2019 May;90(5):522-528. doi: 10.1136/jnnp-2018-318802. Epub 2018 Sep 3.
5
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.多发性硬化症的诊断:2017 年麦当劳标准修订版。
Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21.
6
Benign multiple sclerosis: aspects of cognition and neuroimaging.良性多发性硬化症:认知与神经影像学方面
Arq Neuropsiquiatr. 2017 Jun;75(6):394-401. doi: 10.1590/0004-282X20170043.
7
Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.我们能否预测良性多发性硬化症?一项长达20年的长期随访研究结果。
J Neurol. 2017 Jun;264(6):1068-1075. doi: 10.1007/s00415-017-8487-y. Epub 2017 Apr 17.